The Competition Commission of India (CCI) has approved acquisition of majority shareholding of Glenmark Life Sciences (GLS) Limited by the Nirma Limited.
Synthimed Labs is a recently incorporated company, set up to facilitate the proposed combination, and it is not engaged in any business activities as on date.